YOLFTbeta
24

T&R Biofab Co. Ltd

246710 · KQ · Healthcare / Medical Devices

1,809.00KRW-37.00 (-2.00%)

Price History

Full chart

Market Stats

Previous Close1,846.00
Open1,809.00
Day Range1,790.00 – 1,889.00
52-Week Range1,127.00 – 4,925.00
Volume189.27K
Market Cap109.64B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta0.44
50-Day Avg2,400.40
200-Day Avg2,794.20

About

T&R Biofab Co., Ltd. develops and commercializes various regenerative medical technologies. It offers 3D-printed medical devices; and bio-surgical solutions, which includes wound dressing and acellular dermal matrix, as well as biomaterials and biopharmaceuticals. The company was founded in 2013 and is based in Siheung-si, South Korea.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOWonsoo Yun
  • Employees86
  • Headquarters96, Mayu-ro, Siheung-si, South Korea, 15111, Korea
  • Websitehttps://www.tnrbiofab.com

Leadership

  • Wonsoo YunCPO, CEO & President

Financials

Income Statement

Currency: KRW2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue73.10M274.21M405.54M974.32M1.29B6.81B3.23B5.75B5.20B4.87B26.97B
Growth (%)-+275.11%+47.90%+140.25%+32.11%+428.71%-52.47%+77.90%-9.65%-6.26%+453.32%
Cost of Revenue32.48M220.10M299.44M692.86M678.30M4.15B3.45B4.21B4.12B2.74B20.09B
Gross Profit40.62M54.11M106.10M281.46M608.82M2.66B-212.49M1.54B1.08B2.13B6.88B
Gross Margin55.57%19.73%26.16%28.89%47.30%39.08%-6.57%26.79%20.71%43.74%25.51%
Operating Expense1.15B3.15B4.27B5.22B7.47B8.17B10.22B9.58B14.62B10.90B15.45B
Operating Income-1.11B-3.10B-4.16B-4.93B-6.86B-5.51B-10.43B-8.04B-13.54B-8.77B-8.57B
Operating Margin-1521.59%-1130.65%-1025.58%-506.39%-532.94%-80.95%-322.37%-139.76%-260.51%-179.92%-31.78%
EBITDA--------8.39B-11.26B-2.20B-20.83B
EBITDA Margin--------145.75%-216.56%-45.24%-77.26%
Net Income-1.24B-3.02B-4.06B-4.69B-6.25B-5.60B-11.08B-10.34B-13.42B-7.68B-31.95B
Net Income Margin-1696.46%-1101.30%-1000.66%-481.71%-485.66%-82.36%-342.64%-179.63%-258.10%-157.55%-118.48%
R&D83.71M384.77M1.65B1.96B2.23B3.33B2.82B3.47B4.40B5.51B4.52B
R&D as % of Total Revenue114.52%140.32%406.01%201.17%173.28%49.00%87.11%60.32%84.61%113.05%16.77%
Interest Expense0000015.78M47.33M2.57B3.24M2.20M6.08B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.23%1.46%44.63%0.06%0.05%22.56%

Balance Sheet

Currency: KRW2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets5.45B9.59B9.47B31.10B27.09B48.51B82.23B75.94B99.82B98.45B92.71B
Total Liabilities1.87B738.36M395.46M837.09M2.33B2.45B40.54B36.67B68.62B74.24B66.64B
Total Equity3.58B8.85B9.07B30.27B24.76B46.05B41.69B39.26B31.20B24.21B26.07B
Cash2.93B8.06B7.30B9.66B4.72B23.28B23.66B35.12B20.23B16.67B7.76B
Total Debt----649.92M497.87M-----
Net Debt------5.50B-24.27B26.43B20.78B

Cash Flow

Currency: KRW2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.05B-2.59B-3.72B-5.66B-5.17B-8.38B-7.56B-5.89B-6.96B-11.73B-7.47B
Investing Cash Flow-2.20B851.05M-706.17M-19.18B-270.89M1.03B-33.78B17.58B-37.52B11.69B-
Financing Cash Flow3.77B6.87B3.68B27.19B511.52M26.03B41.66B-219.47M29.58B-3.51B-
Capital Expenditure126.61M643.71M214.15M452.29M668.04M1.69B1.13B10.83B12.73B2.81B2.40B
Free Cash Flow------10.54B-16.60B-16.92B-19.69B-14.54B-9.87B
FCF to OCF-----125.83%219.53%287.46%282.81%123.94%132.17%

Earnings

Report DateMar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Mar 17, 2021May 17, 2021Aug 17, 2021Nov 15, 2021Feb 11, 2022May 15, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate------------------------------
EPS Actual-70.60-56.16-63.20-59.69-66.04-11.65-76.47-101.37-116.50-135.00-142.50-394.54-288.00-130.13-92.647.32-114.91-127.23-168.47-8.38-238.29-29.37-146.42177.90-165.70-131.80-220.96-403.17-34.92-79.36
Surprise------------------------------
Timing-------After-hoursPre-marketPre-marketPre-marketPre-marketAfter-hours-----------------

Key Statistics & Ratios

Market Cap109.64B
Enterprise Value133.32B
Trailing P/E0.00
Forward P/E0.00
Price / Sales3.35
Price / Book5.14
Revenue (TTM)32.73B
Gross Profit (TTM)10.20B
EBITDA-358.15M
Profit Margin-84.66%
Operating Margin-12.10%
Return on Equity-127.88%
Return on Assets-3.50%
Shares Outstanding47.56M
Shares Float40.55M
Beta0.44
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Oct 29, 20256:5
  • Sep 9, 20252053:1631
  • Apr 5, 20222:1